Delivery Order SPE2DB20D9331-SPE2DB25FL1J0

Award Date 5/23/25
Potential Completion Date 6/16/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,000.32, is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,000.32, is for the provision of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a specialized pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,737.40 contract is for the delivery of Zosyn 3.375 gm/50 ml Galaxy 50 ml, a pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The award is not associated with a set-aside designation, which allows DMS Pharmaceutical Group to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,000.32, is for the procurement of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.40 contract is for the delivery of 4559906717 - ZOSYN 3.375 GM/50 ML GALAXY 50ML, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,243.84 contract covers the delivery of 4567537209 - ZOSYN 3.375 GM/50 ML GALAXY 50ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of March 18, 2025. DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,000.64, is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,541.16 contract is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical products to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,000.32, is for the delivery of the pharmaceutical product ZOSYN 3.375 GM/50 ML GALAXY 50ML to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,081.20, is for the provision of the pharmaceutical product ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The contract is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1J0
    Delivery Order

This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is valued at $1,667.20 and has an ultimate completion date of June 16, 2025.

The contract is for the supply of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

This contract award does not have a set-aside designation, and DMS Pharmaceutical Group has consistently secured contracts without specific set-aside designations, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.

Generated 8/22/25, 10:06 AM